Abstract
Rheumatic diseases are characterized by complex pathogenic mechanisms, with intricate signaling pathways and various imbalances of proinflammatory and anti-inflammatory cytokines, especially in the case of immune-inflammatory conditions [...].
MeSH terms
-
Anti-Inflammatory Agents / therapeutic use
-
Cytokines / therapeutic use
-
Humans
-
Rheumatic Diseases* / drug therapy
-
Rheumatology*
-
Signal Transduction
Substances
-
Cytokines
-
Anti-Inflammatory Agents
Grants and funding
This research received no external funding.